REZDIFFRAREZDIFFRAREZDIFFRA

This indication is accredited beneath accelerated acceptance based on enhancement of NASH and fibrosis [see Scientific Research (fourteen)]. Continued approval for this indication could possibly be contingent upon verification and description of medical gain in confirmatory trials.Under is a listing of medicines that could interact with Rezdiffra.